Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

PHYTOLOOP – In Vitro Platform To Produce High-Value APIs From Endangered Endemic Plants

Ziel

PHYTOLOOP is a deep-tech biomanufacturing project by Kanara (Vulkania Labs S.L.) that enables the sustainable, traceable and scalable production of high-value plant-derived Active Pharmaceutical Ingredients (APIs) from endangered and endemic species, starting with the Canary Islands’ unique flora. The project replaces destructive wild harvesting and inefficient agricultural extraction with a modular, AI-assisted in-vitro platform that cultivates plant cells in closed bioreactors under fully controlled, sterile conditions.

The approach integrates AI-driven optimisation, advanced plant biotechnology and automated bioreactors to drastically reduce trial-and-error in media formulation and process control, achieving ≥50 % fewer optimisation cycles, ≥20 % lower production cost and reproducible yields with <10 % batch variability. By maintaining elite, high-yielding cell lines ex-situ, the system ensures perpetual access to valuable APIs while conserving biodiversity.

Over 24 months, PHYTOLOOP will evolve from TRL 4 to TRL 6, delivering a validated 50 L automated pilot line and a regulatory-ready platform for pharmaceutical adoption. The project includes four technical and business objectives:

1. Establish stable in-vitro cell lines from at least three endangered endemic species;
2. Integrate and automate the full pilot-scale bioprocess;
3. Validate market demand through Letters of Intent and an investor-ready data room;
4. Define GMP and industrialisation roadmaps for post-project pilots.

Backed by confirmed LOIs from pharma and institutional partners (Adventia Pharma, MOEVE, CSIC, ICIA) and co-funded 30 % by Kanara, PHYTOLOOP anchors a new biodiversity-based bio-industry in the Canary Islands, strengthening EU strategic autonomy in APIs while creating a replicable, nature-positive model of industrial biotechnology.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-CSA - HORIZON Coordination and Support Actions

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-WIDERA-2025-02

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

VULKANIA LABS SL
Netto-EU-Beitrag
€ 499 476,95
Adresse
LA CUESTA 17 LA CUESTA DE LA VILLA
38390 SANTA URSULA SANTA CRUZ DE TENERIFE
Spanien
KMU
Ja
Region
Canarias Canarias Tenerife
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
Keine Daten